Alexander Drilon

Author Correction: Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms

Benjamin Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic, David Abramson et autres

us, be, es, fr (code pays fourni par la source)

A Phase 2 Basket Trial of Ado-Trastuzumab Emtansine for Patients with HER2 Amplified Cancers: A Non-Randomized Clinical Trial

Jessica C. Stuart, Winston Wong, Lauren Schoech, Alex Makhnin et autres

us (code pays fourni par la source)

The Pan-tumor Landscape, Allelic Status, and Genomic Complexity of SMARCA4 Alterations

Matteo Repetto, Michael V. Gormally, Jason C. Chang, Pier Selenica et autres

us (code pays fourni par la source)

Supplemental Figures 1 from Molecular Lineages of Sporadic Mismatch Repair–Deficient Colorectal Cancer

Michael B. Foote, Guilherme Harada, Somer Abdelfattah, Nil Urgancı et autres

Supplementary Table S1 from Molecular Lineages of Sporadic Mismatch Repair–Deficient Colorectal Cancer

Michael B. Foote, Guilherme Harada, Somer Abdelfattah, Nil Urgancı et autres

Supplementary Table S4 from Molecular Lineages of Sporadic Mismatch Repair–Deficient Colorectal Cancer

Michael B. Foote, Guilherme Harada, Somer Abdelfattah, Nil Urgancı et autres

Supplementary Table S2 from Molecular Lineages of Sporadic Mismatch Repair–Deficient Colorectal Cancer

Michael B. Foote, Guilherme Harada, Somer Abdelfattah, Nil Urgancı et autres

Supplementary Table S3 from Molecular Lineages of Sporadic Mismatch Repair–Deficient Colorectal Cancer

Michael B. Foote, Guilherme Harada, Somer Abdelfattah, Nil Urgancı et autres

Supplementary Table S5 from Molecular Lineages of Sporadic Mismatch Repair–Deficient Colorectal Cancer

Michael B. Foote, Guilherme Harada, Somer Abdelfattah, Nil Urgancı et autres

Data from Molecular Lineages of Sporadic Mismatch Repair–Deficient Colorectal Cancer

Michael B. Foote, Guilherme Harada, Somer Abdelfattah, Nil Urgancı et autres

Data from Retreatment with First-Generation Selective RET Inhibitors in RET-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib: Results from the RET-MAP Registry

Arianna Marinello, Julia Rotow, Meghanne Lomibao, Daniela Miliziano et autres

Supplementary Data1 from Retreatment with First-Generation Selective RET Inhibitors in RET-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib: Results from the RET-MAP Registry

Arianna Marinello, Julia Rotow, Meghanne Lomibao, Daniela Miliziano et autres